Patricia Inacio, PhD - Science Writer | Rett Syndrome News
Patricia Inacio is a science writer for Rett Syndrome News with a PhD in cell biology. She covers the latest news and information on a variety of Rett syndrome topics.| Rett Syndrome News
Patricia Inacio is a science writer for Rett Syndrome News with a PhD in cell biology. She covers the latest news and information on a variety of Rett syndrome topics.| Rett Syndrome News
Approved in the U.S. in March 2023, Daybue (trofinetide) is a daily treatment for Rett syndrome that can be taken by mouth or feeding tube.| Rett Syndrome News
Trofinetide significantly reduced neurobehavioral symptoms and improved communication in females with Rett syndrome, the LAVENDER trial shows.| Rett Syndrome News
Category archive page for News.| Rett Syndrome News
Long-term treatment with Daybue (trofinetide) led to continual improvements in symptoms in people with Rett syndrome in extension studies, data show.| Rett Syndrome News
Learn more about the rare neurodevelopmental disorder Rett syndrome, including its causes, symptoms, diagnosis and treatment.| Rett Syndrome News
